Consommation d’alcool et d’autres produits psychoactifs pendant la pandémie de Covid-19 dans la Global Drug Survey : une perspective française (notice n° 806824)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03738cam a2200505 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250123123912.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Jauffret-Roustide, Marie |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Consommation d’alcool et d’autres produits psychoactifs pendant la pandémie de Covid-19 dans la Global Drug Survey : une perspective française |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2020.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 46 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | La Global Drug Survey est une enquête en ligne visant à étudier l’expérience des usagers de drogues en population générale, menée chaque année entre novembre et décembre. Ce volet spécial Covid-19 a été réalisé sur sept semaines, de mai à juin 2020. L’enquête avait comme objectif d’explorer de manière rétrospective l’impact du confinement et des premières semaines du déconfinement sur les consommations de produits psychoactifs en population générale. Les résultats de l’enquête mettent en évidence une augmentation du nombre de jours de consommation d’alcool, mais pas d’augmentation du binge drinking. Pour le cannabis, les usages sont restés relativement stables, même si une augmentation relative en comparaison aux autres pays est observée. Les usages d’ecstasy et de cocaïne ont baissé tout particulièrement. Enfin, les benzodiazépines ont vu leur usage augmenter. La Global Drug Survey note que la pandémie a modifié les usages de produits psychoactifs, sans qu’une augmentation des conduites dérégulées ne soit observée. Les usagers ont adapté leurs pratiques en fonction des modifications relatives à leur environnement de vie. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The Global Drug Survey is an online survey that aimed to explore the experience of people who use drugs in general population. This survey is conducted annually between November and December. This special Covid-19 component was conducted over seven weeks, from May to June 2020. The objective of the survey was to retrospectively explore the impact of confinement and the first weeks after lockdown on the consumption of psychoactive products in the general population. The results of the survey show an increase in the number of drinking days, but no increase in binge drinking. For cannabis, use remained relatively stable, although a relative increase compared to other countries was observed. The trends of ecstasy and cocaine uses in particular declined. Finally, benzodiazepines have seen their use increase. The Global Drug Survey notes that the pandemic has changed the patterns of use of psychoactive products, without an increase in deregulated behaviours being observed. People who use drugs have adapted their practices in line with changes in their social environment. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | ecstasy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | expérience |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | enquête |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cocaïne |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | drogues |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cannabis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Covid-19 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | benzodiazépines |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Global Drug Survey |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | alcool |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | ecstasy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | benzodiazepines |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | survey |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | experience |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | alcohol |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cannabis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Covid-19 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cocaine |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Global Drug Survey |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | drugs |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barratt, Monica |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | de Dinechin, Sébastien |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Davies, Emma |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gilchrist, Gail |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hughes, Caitlin |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Maier, Larissa |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ferris, Jason |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Winstock, Adam |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Psychotropes | 26 | 2 | 2020-11-24 | p. 209-219 | 1245-2092 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-psychotropes-2020-2-page-209?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-psychotropes-2020-2-page-209?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux